A prospective comparison of 18F-FDG PET/CT and CT as diagnostic tools to identify the primary tumor site in patients with extracervical carcinoma of unknown primary site

Oncologist

Volumn 17, Issue 9, 2012, Pages 1146-1154

  Møller, Anne Kirstine H ^a   Loft, Annika ^a   Berthelsen, Anne K ^a   Pedersen, Karen D ^a   Graff, Jesper ^c   Christensen, Charlotte B ^a   Costa, Junia C ^a   Skovgaard, Lene T ^d   Perell, Katharina ^a   Petersen, Bodil L ^b   Daugaard, Gedske ^a  

^a Department of Oncology ^*  (Denmark)

^b Rigshospitalet   (Denmark)

^c Mental Health Services CPH   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

18F FDG PET CT; Carcinoma of unknown primary tumor site; CT; CUP

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; IOVERSOL; IOXITALAMAT; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER OF UNKNOWN PRIMARY SITE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; OBSERVER VARIATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; COMPARATIVE STUDY; LYMPH NODE METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; UTERINE CERVIX TUMOR;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 84866559357     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2011-0449     Document Type: Article

References (26)

1. Pavlidis N, Briasoulis E, Hainsworth J et al. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003;39:1990-2005.
2. Pavlidis N, Fizazi K. Carcinoma of unknown primary(CUP). Crit Rev Oncol Hematol 2009;69:271-278.
3. Fizazi K. Treatment of patients with specific subsets of carcinoma of an unknown primary site. Ann Oncol 2006;17(suppl 10):x177-x180.
4. Hainsworth JD, Fizazi K. Treatment for patients with unknown primary cancer and favorable prognostic factors. Semin Oncol 2009;36:44-51.
5. Daugaard G, Moller AK, Petersen BL. Cancer of un- knownprimarysite. In: CavalliF, Hansen H, Kaye Setal., eds. Textbook of Medical Oncology, Fourth Edition. London,United Kingdom: InformaHealthcare,2009:313-322.
6. Pentheroudakis G, Golfinopoulos V, Pavlidis N. Switching benchmarks in cancer of unknown primary: From autopsy to microarray. Eur J Cancer 2007;43: 2026-2036.
7. Poeppel TD, Krause BJ, Heusner TA et al. PET/CT for the staging and follow-up of patients with malignancies. Eur J Radiol 2009;70:382-392.
8. Fischer B, Lassen U, Mortensen J et al. Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 2009;361:32-39.
9. Lardinois D, Weder W, Hany TF et al. Staging of non-small-cell lung cancer with integrated positron- emission tomography and computed tomography. N Engl J Med 2003;348:2500-2507.
10. 18FDG-PET in the detection and management of patients with lymph node metastases to the neck from an unknown primary tumor. Results from the DAH-ANCA-13 study. Head Neck 2008;30:471-478.
11. Keller F, Psychogios G, Linke R et al. Carcinoma of unknown primary in the head and neck: Comparison between positron emission tomography (PET) and PET/ CT. Head Neck 2011;33:1569-1575.
12. Roh JL, Kim JS, Lee JH et al. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors. Oral Oncol 2009;45:218-224.
13. Rusthoven KE, Koshy M, Paulino AC. The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor. Cancer 2004;101:2641-2649.
14. Kwee TC, Kwee RM. Combined FDG-PET/CT for the detection of unknown primary tumors: Systematic reviewandmeta-analysis. Eur Radiol 2009;19:731-744.
15. 18F-FDG PET/CT as a diagnostic tool in patients with extracervical carcinoma of unknown primary site: A literature review. The Oncologist 2011;16:445-451.
16. Fizazi K, Greco FA, Pavlidis N et al. Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2011;22(suppl 6):vi64-vi68.
17. 18F-fluorodeoxyglucose positron emission tomography/computed tomography in carcinoma of an unknown primary: Diagnosis and follow-up. Nucl Med Commun 2010;31:59-66.
18. Gutzeit A, Antoch G, Kḧl H et al. Unknown primary tumors: Detection with dualmodality PET/CT-initial experience. Radiology 2005;234:227-234.
19. Veit-Haibach P, Luczak C, Wanke I et al. TNM stagingwithFDG-PET/CTinpatientswithprimaryhead and neck cancer. Eur J Nucl Med Mol Imaging 2007;34: 1953-1962.
20. 18F -FDG PET/CTintheassessmentofcarcinomaofunknownprimary origin. Radiol Med 2006;111:1146-1155.
21. 18F -fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknownprimary site. Q J Nucl Med Mol Imaging 2006;50:15-22.
22. Park JS, Yim JJ, Kang WJ et al. Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT. BMC Res Notes 2011;4:56.
23. Multidetector-RowComputedTomography:Scanning and Contrast Protocols. Marchal G, Vogl TJ, Heiken JP, Rubin GD, eds. Milan, Italy: Springer, 2005:1-130.
24. Greco FA, Spigel DR, Yardley DA et al. Molecular profiling in unknown primary cancer: Accuracy of tissue of origin prediction. The Oncologist 2010;15:500-506.
25. Morawietz L, Floore A, Stork-Sloots L et al. Comparison of histopathological and gene expressionbased typing of cancer of unknown primary. Virchows Arch 2010;456:23-29.
26. Varadhachary GR, Talantov D, Raber MN et al. Molecular profiling of carcinoma of unknown primary and correlation with clinical evaluation. J Clin Oncol 2008;26:4442-4448.